Cholesterol regulates μ-opioid receptor-induced β-arrestin 2 translocation to membrane lipid rafts

Molecular Pharmacology

Volumn 80, Issue 1, 2011, Pages 210-218

  Qiu, Yu ^a,b   Wang, Yan ^b   Law, Ping Yee ^a   Chen, Hong Zhuan ^b   Loh, Horace H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; BISINDOLYLMALEIMIDE; BISINDOLYLMALEIMIDE X HYDROCHLORIDE; CHOLESTEROL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MEMBRANE LIPID; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MU OPIATE RECEPTOR; PROTEIN KINASE C; RO 318425; SIMVASTATIN; UNCLASSIFIED DRUG; BETA ARRESTIN; OPIATE RECEPTOR; RETINA S ANTIGEN;

ANIMAL CELL; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; LIPID RAFT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; ANIMAL; DRUG POTENTIATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN TRANSPORT; TUMOR CELL CULTURE;

ANIMALS; ARRESTINS; CHOLESTEROL; MEMBRANE LIPIDS; MICE; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTORS, OPIOID; TUMOR CELLS, CULTURED;

EID: 79959292418     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.070870     Document Type: Article

References (40)

1. Abrami L, Liu S, Cosson P, Leppla SH, and van der Goot FG (2003) Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 160:321-328. (Pubitemid 36182723)
2. Allen JA, Halverson-Tamboli RA, and Rasenick MM (2007) Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8:128-140. (Pubitemid 46146951)
3. Barnett-Norris J, Lynch D, and Reggio PH (2005) Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system. Life Sci 77:1625-1639. (Pubitemid 41073657)
4. Chini B and Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32:325-338.
5. Crane JM and Tamm LK (2004) Role of cholesterol in the formation and nature of lipid rafts in planar and spherical model membranes. Biophys J 86:2965-2979. (Pubitemid 38552700)
6. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
7. Gimpl G, Reitz J, Brauer S, and Trossen C (2008) Oxytocin receptors: ligand binding, signalling and cholesterol dependence. Prog Brain Res 170:193-204. (Pubitemid 352010230)
8. Gómez J, Sague?s F, and Reigada R (2008) Actively maintained lipid nanodomains in biomembranes. Phys Rev E Stat Nonlin Soft Matter Phys 77:021907.
9. Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, and Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature 383:447-450. (Pubitemid 26330835)
10. Harikumar KG, Puri V, Singh RD, Hanada K, Pagano RE, and Miller LJ (2005) Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem 280:2176-2185.
11. Huang P, Xu W, Yoon SI, Chen C, Chong PL, Unterwald EM, and Liu-Chen LY (2007) Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res 1184:46-56. (Pubitemid 350160595)
12. Huttenrauch F, Nitzki A, Lin FT, Höning S, and Oppermann M (2002) Beta-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif. J Biol Chem 277:30769-30777. (Pubitemid 34970774)
13. Kubale V, Abramović Z, Pogacnik A, Heding A, Sentjurc M, and Vrecl M (2007) Evidence for a role of caveolin-1 in neurokinin-1 receptor plasma-membrane localization, efficient signaling, and interaction with beta-arrestin 2. Cell Tissue Res 330:231-245. (Pubitemid 47512587)
14. Le Roy C and Wrana JL (2005) Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6:112-126. (Pubitemid 40215807)
15. Lefkowitz RJ and Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512-517.
16. Levitt ES, Clark MJ, Jenkins PM, Martens JR, and Traynor JR (2009) Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase. J Biol Chem 284:22108-22122.
17. Lingwood D, Kaiser HJ, Levental I, and Simons K (2009) Lipid rafts as functional heterogeneity in cell membranes. Biochem Soc Trans 37:955-960.
18. Macdonald JL and Pike LJ (2005) A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 46:1061-1067.
19. Minnis JG, Patierno S, Kohlmeier SE, Brecha NC, Tonini M, and Sternini C (2003) Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons. Neuroscience 119:33-42. (Pubitemid 36577409)
20. Morris DP, Lei B, Wu YX, Michelotti GA, and Schwinn DA (2008) The alpha1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits. J Biol Chem 283:2973-2985.
21. Nair KS, Balasubramanian N, and Slepak VZ (2002) Signal-dependent translocation of transducin, RGS9-1-Gbeta5L complex, and arrestin to detergent-resistant membrane rafts in photoreceptors. Curr Biol 12:421-425.
22. Pike LJ and Casey L (2002) Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41:10315-10322. (Pubitemid 34856457)
23. Puri C, Tosoni D, Comai R, Rabellino A, Segat D, Caneva F, Luzzi P, Di Fiore PP, and Tacchetti C (2005) Relationships between EGFR signaling-competent and endocytosis-competent membrane microdomains. Mol Biol Cell 16:2704-2718. (Pubitemid 40741218)
24. Qiu Y, Law PY, and Loh HH (2003) Mu-opioid receptor desensitization: role of receptor phosphorylation, internalization, and representation. J Biol Chem 278: 36733-36739.
25. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, and Sandvig K (1999) Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 10:961-974. (Pubitemid 29193724)
26. Rollason R, Korolchuk V, Hamilton C, Schu P, and Banting G (2007) Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120:3850-3858. (Pubitemid 350187366)
27. Romanenko VG, Roser KS, Melvin JE, and Begenisich T (2009) The role of cell cholesterol and the cytoskeleton in the interaction between IK1 and maxi-K channels. Am J Physiol Cell Physiol 296:C878-C888.
28. Sarnataro D, Caputo A, Casanova P, Puri C, Paladino S, Tivodar SS, Campana V, Tacchetti C, and Zurzolo C (2009) Lipid rafts and clathrin cooperate in the internalization of PrP in epithelial FRT cells. PLoS One 4:e5829.
29. Simons K and Ehehalt R (2002) Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603. (Pubitemid 34988781)
30. Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, and Brodsky FM (2002) Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity 17:451-462. (Pubitemid 35223534)
31. Subtil A, Gaidarov I, Kobylarz K, Lampson MA, Keen JH, and McGraw TE (1999) Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc Natl Acad Sci USA 96:6775-6780. (Pubitemid 29274959)
32. von Zastrow M (2003) Mechanisms regulating membrane trafficking of G protein-coupled receptors in the endocytic pathway. Life Sci 74:217-224.
33. von Zastrow M, Svingos A, Haberstock-Debic H, and Evans C (2003) Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr Opin Neurobiol 13:348-353. (Pubitemid 36792248)
34. Waldhoer M, Bartlett SE, and Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990. (Pubitemid 39050391)
35. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95:9914-9919. (Pubitemid 28415269)
36. Xue M, Vines CM, Buranda T, Cimino DF, Bennett TA, and Prossnitz ER (2004) N-formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation. J Biol Chem 279:45175-45184. (Pubitemid 39430933)
37. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, and Caron MG (1998) Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 95:7157-7162. (Pubitemid 28278123)
38. Zhao H, Loh HH, and Law PY (2006) Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol 69:1421-1432.
39. Zheng H, Chu J, Qiu Y, Loh HH, and Law PY (2008a) Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci USA 105:9421-9426.
40. Zheng H, Loh HH, and Law PY (2008b) Beta-arrestin-dependent mu-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation. Mol Pharmacol 73:178-190. (Pubitemid 350294209)